Safety and efficacy of subtotal or total parathyroidectomy for patients with secondary or tertiary hyperparathyroidism in four academic centers in the NetherlandsDutch Hyperparathyroidism Study Group (DHSG), van der Plas, W. Y., Dulfer, R. R., Koh, E. Y., Vogt, L., Appelman-Dijkstra, N. M., Schepers, A., Rotmans, J. I., Pol, R. A., van Ginhoven, T. M., Hoorn, E. J., Nieveen van Dijkum, E. J. M., Engelsman, A. F., de Borst, M. H. & Kruijff, S., Dec-2018, In : Langenbecks Archives of Surgery. 403, 8, p. 999-1005 7 p.
Research output: Contribution to journal › Article › Academic › peer-review
PURPOSE: Hyperparathyroidism (HPT) is a common abnormality in patients with end-stage renal disease (ESRD). Since the introduction of cinacalcet in 2004, a shift from surgery toward predominantly medical treatment has occurred. Surgery is thought to be associated with more complications than oral medication. The aim of this retrospective study was to evaluate 30-day outcomes and effectiveness of parathyroidectomy (PTx) in ESRD patients in the Netherlands.
METHODS: A national database containing data from four academic medical centers in the Netherlands of patients with ESRD-related HPT, who had undergone PTx and kidney transplantation between 1994 and 2015, was established. Primary endpoints were 30-day mortality and complication rate. Secondary endpoints were biochemical measurements.
RESULTS: We identified 187 HPT patients undergoing PTx, with a median age of 46 years. Median preoperative PTH level was 866 pg/mL (interquartile range [IQR] 407-1547 pg/mL). At 3 months, the median PTH drop from baseline was 93% (IQR, 71-98%) to a median of 61 pg/mL (IQR, 23-148 pg/mL, p < 0.001). Over the 25-year inclusion period, 13 patients (7.0%) required re-exploration for persistent or recurrent disease. Thirty-day mortality and complication rate were 0.0% and 7.9% respectively. Median serum calcium levels improved significantly postoperatively from 2.6 (2.4-2.8) mmol/L to 2.3 (2.1-2.5) mmol/L (p < 0.001).
CONCLUSIONS: PTx is a safe and effective procedure in the frail ESRD population. These data show that there should be no reluctance for surgical intervention and when indicated, nephrologists can safely refer these patients for PTx.
|Number of pages||7|
|Journal||Langenbecks Archives of Surgery|
|Publication status||Published - Dec-2018|